In the capital market, an invisible acquisition and sniping war has quietly ignited. International capital has begun intensive contact with some small and medium-sized technology companies in the "Breaking Wall" alliance that have made breakthroughs in key raw materials or core components. They offer staggering high prices, promising a vast market prospect after merging with international giants. For those unwilling to sell, what follows will be patent lawsuits, negative reports attacks, and supply chain difficulties at their critical development nodes.
...
The upgrade of the "Trojan Plan" is more fierce and precise than many had expected. For a time, China's biopharmaceutical field, especially the links related to the "Breaking Wall" plan, could be described as dark clouds pressing down on the city.
